KMDA
NASDAQ · Biotechnology
Kamada Ltd
$8.41
+0.15 (+1.82%)
Open$8.54
Previous Close$8.26
Day High$8.55
Day Low$8.36
52W High$9.35
52W Low$6.50
Volume—
Avg Volume37.1K
Market Cap493.22M
P/E Ratio24.42
EPS$0.35
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+245.1% upside
Current
$8.41
$8.41
Target
$29.02
$29.02
$25.25
$29.02 avg
$47.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 181.39M | 162.32M | 67.17M |
| Net Income | 20.30M | 16.35M | -1,989,318 |
| Profit Margin | 11.2% | 10.6% | -3.0% |
| EBITDA | 25.76M | 21.90M | -2,803,887 |
| Free Cash Flow | — | — | -2,727,774 |
| Rev Growth | +11.8% | +11.8% | +14.3% |
| Debt/Equity | 0.04 | 0.04 | 0.09 |
Dividend
Dividend Yield3.03%
Annual Dividend$0.20
Payout Ratio57.1%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |